市場調查報告書
商品編碼
1467588
2024-2032 年介入性心臟病學和周邊血管器材市場(按產品類型、適應症、年齡層、最終用戶和地區分類)Interventional Cardiology and Peripheral Vascular Devices Market by Product Type, Indication, Age Group, End User, and Region 2024-2032 |
2023年,IMARC Group介入性心臟病學和周邊血管器械市場規模達250億美元。 。患有慢性心臟病的人數不斷增加,週邊動脈疾病(PAD)發病率激增,以及消費者對微創(MI)手術的偏好不斷上升,是推動市場發展的一些關鍵因素。
介入性心臟病學是指心臟病學的次專業,依靠血管內導管技術和透視技術來治療多種瓣膜疾病、冠狀動脈疾病和先天性心臟病。另一方面,週邊血管裝置是用於治療動脈阻塞和血管狹窄的醫療裝置,特別是在周邊脈管系統中,導致流向身體不同部位的血流減少。這些介入方法通常用於治療影響循環系統的心臟病和周圍血管疾病,以避免併發症和疤痕,同時最大限度地減少疼痛並促進更快的康復。因此,介入性心臟病學和周邊血管裝置在治療各種結構性心臟病和動脈相關疾病以及週邊血管內和冠狀動脈手術中得到了廣泛的應用。
患有冠狀動脈疾病 (CAD) 等慢性心臟病的人數不斷增加,更加需要早期發現和干涉,以防止致命後果。再加上週邊動脈疾病(PAD)發生率的上升,是推動市場成長的主要因素。此外,患者和醫療保健專業人員從傳統手術轉向微創 (MI) 手術,因為微創手術切口較小、手術疼痛、損傷和疤痕更少、住院時間更短、準確性更高且恢復更快。與此一致的是,不斷成長的老年人口正在加劇全球心臟病和血管疾病的負擔,這反過來又增加了產品需求。此外,由於技術的快速進步,領先的製造商正在開發新型介入性心臟病學和周邊血管設備的創新變體,以獲得更好的治療效果。同時,主要參與者不斷推出產品和不斷增加的產品批准數量推動了市場成長。其他因素,包括生物可吸收支架的引入、急診和重症監護入院病例的增加、有利的報銷政策、改善醫療基礎設施以及持續的研發(R&D)活動,也為市場成長提供了積極的推動力。
The global interventional cardiology and peripheral vascular devices market size reached US$ 25.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 47.0 Billion by 2032, exhibiting a growth rate (CAGR) of 7.07% during 2024-2032. The increasing number of individuals suffering from chronic heart conditions, surging incidences of peripheral arterial disease (PAD), and rising consumer preferences for minimally invasive (MI) procedures represent some of the key factors driving the market.
Interventional cardiology refers to the sub-specialty of cardiology that relies on intravascular catheter-based techniques with fluoroscopy to treat numerous valvular, coronary artery, and congenital heart diseases. On the other hand, peripheral vascular devices are medical devices used for treating artery blockages and narrowing of blood vessels, especially in the peripheral vasculature, resulting in reduced blood flow to different body parts. These interventional methods are commonly employed for managing cardiology diseases and peripheral vascular disorders affecting the circulatory system to avoid complications and scars while minimizing pain and promoting faster recovery. As a result, interventional cardiology and peripheral vascular devices find extensive applications in the treatment of various structural heart diseases and artery-related ailments, as well as in peripheral endovascular and coronary procedures.
The increasing number of individuals suffering from chronic heart conditions, such as coronary artery diseases (CADs), has strengthened the need for early detection and intervention to prevent fatal consequences. This, coupled with the rising incidences of peripheral arterial disease (PAD), represents the primary factor driving the market growth. Additionally, there has been a substantial shift from traditional surgeries toward minimally invasive (MI) procedures among patients and healthcare professionals as they involve smaller incisions, less surgical pain, injury, and scarring, shorter hospital stays, higher accuracy, and quick recovery. In line with this, the expanding geriatric population is contributing to the growing burden of cardiological and vascular diseases across the globe, which in turn has augmented the product demand. Furthermore, due to rapid technological advancements, the leading manufacturers are developing new and innovative variants of interventional cardiology and peripheral vascular devices for better treatment outcomes. Along with this, continuous product launches by key players and the increasing number of product approvals have propelled market growth. Other factors, including the introduction of bio-absorbable stents, rising admission cases in emergency and critical care, favorable reimbursement policies, improving healthcare infrastructure, and ongoing research and development (R&D) activities, are also providing a positive thrust to the market growth.
IMARC Group provides an analysis of the key trends in each segment of the global interventional cardiology and peripheral vascular devices market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on product type, indication, age group, and end user.
Inferior Vena Cava (IVC) Filters
Plaque Modification Devices
Hemodynamic Flow Alteration Devices
Accessories
Angioplasty Balloons
Angioplasty Stents
Angioplasty Catheters
Endovascular Aneurysm Repair Stent Grafts
The report has provided a detailed breakup and analysis of the interventional cardiology and peripheral vascular devices market based on the product type. This includes inferior vena cava (IVC) filters, plaque modification devices, hemodynamic flow alteration devices, accessories, angioplasty balloons, angioplasty stents, angioplasty catheters, and endovascular aneurysm repair stent grafts. According to the report, angioplasty balloons represented the largest segment.
Coronary Intervention
Peripheral Arterial Disease
A detailed breakup and analysis of the interventional cardiology and peripheral vascular devices market based on the indication has also been provided in the report. This includes coronary intervention and peripheral arterial disease.
Geriatric
Adults
Paediatric
The report has provided a detailed breakup and analysis of the interventional cardiology and peripheral vascular devices market based on the age group. This includes geriatric, adults, and paediatric. According to the report, geriatric represented the largest segment.
Hospitals
Ambulatory Surgical Centers
Others
The report has provided a detailed breakup and analysis of the interventional cardiology and peripheral vascular devices market based on the end user. This includes hospitals, ambulatory surgical centers, and others. According to the report, hospitals represented the largest segment.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for interventional cardiology and peripheral vascular devices. Some of the factors driving the North America interventional cardiology and peripheral vascular devices market included its rapidly aging population, the presence of a large patient pool, increasing healthcare expenditure, etc.
The report has also provided a comprehensive analysis of the competitive landscape in the global interventional cardiology and peripheral vascular devices market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Abbott Laboratories, B. Braun Melsungen AG, Becton Dickinson and Company, Biotronik SE & Co. KG, Boston Scientific Corporation, Cook Group Incorporated, Cordis Corporation, Koninklijke Philips N.V., Medtronic plc., Teleflex Incorporated, Terumo Corporation, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.